LLY

890.37

+1.41%↑

JNJ

242.43

+0.9%↑

ABBV

212.4

+1.3%↑

NVS

150.25

+1.35%↑

MRK

117.53

-1.8%↓

LLY

890.37

+1.41%↑

JNJ

242.43

+0.9%↑

ABBV

212.4

+1.3%↑

NVS

150.25

+1.35%↑

MRK

117.53

-1.8%↓

LLY

890.37

+1.41%↑

JNJ

242.43

+0.9%↑

ABBV

212.4

+1.3%↑

NVS

150.25

+1.35%↑

MRK

117.53

-1.8%↓

LLY

890.37

+1.41%↑

JNJ

242.43

+0.9%↑

ABBV

212.4

+1.3%↑

NVS

150.25

+1.35%↑

MRK

117.53

-1.8%↓

LLY

890.37

+1.41%↑

JNJ

242.43

+0.9%↑

ABBV

212.4

+1.3%↑

NVS

150.25

+1.35%↑

MRK

117.53

-1.8%↓

Home・Akciju saraksts・Evolent Health Inc

Evolent Health Inc

Atvērts

SektorsVeselības aprūpe

2.14 -3.6

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.13

Max

2.25

Galvenie mērījumi
By Trading Economics
Ienākumi	-408M -429M
Pārdošana	-11M 469M
Peļņas marža	-91.554
Darbinieki	4,200
EBITDA	-374M -360M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt (spēcīgs)
Prognoze 12 mēnešiem	+150.68% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 7. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-43M 278M
Iepriekšējā atvēršanas cena	5.74
Iepriekšējā slēgšanas cena	2.14

Ziņu noskaņojums

By Acuity

57%

43%

280 / 349 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bullish Evidence

10.33 / 10.95 Atbalsts un pretestība

Evolent Health Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 27. marts 17:33 UTC

Galvenie ziņu notikumi

ECB Should Not Rush Its Response to Iran Conflict, Says Schnabel -- Update

2026. g. 27. marts 17:00 UTC

Galvenie ziņu notikumi

ECB Shouldn't Rush Its Response to Iran Conflict, Schnabel Says

2026. g. 27. marts 16:03 UTC

Galvenie ziņu notikumi

Fertilizer Maker Yara Warns Farmers Are Being Squeezed by Price Surge Amid War -- Commodities Roundup

2026. g. 29. marts 23:47 UTC

Tirgus saruna

Galvenie ziņu notikumi

Gold Falls Amid Rising Inflation Fears -- Market Talk

2026. g. 29. marts 23:46 UTC

Tirgus saruna

Galvenie ziņu notikumi

Nikkei May Fall on Fears About Shortage of Petrochemical Products -- Market Talk

2026. g. 29. marts 23:35 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Rises on Supply-Disruption Concerns Spurred by Widening Mideast Conflict -- Market Talk

2026. g. 29. marts 23:23 UTC

Tirgus saruna

Australia's National Cabinet to Avoid Covid-Style Measures -- Market Talk

2026. g. 29. marts 22:34 UTC

Tirgus saruna

Macroeconomic Tailwind for Warehouse Dissipates -- Market Talk

2026. g. 29. marts 22:09 UTC

Tirgus saruna

Amplitude's Next Well "Effectively a Must-Win" for Growth Thesis -- Market Talk

2026. g. 29. marts 21:06 UTC

Tirgus saruna

Galvenie ziņu notikumi

Australia's Economy Could Already Be Contracting Amid Oil Shock -- Market Talk

2026. g. 29. marts 21:03 UTC

Tirgus saruna

Australia's Government Wants to Avoid Heavy Handed Oil Shock Response -- Market Talk

2026. g. 29. marts 21:01 UTC

Tirgus saruna

Galvenie ziņu notikumi

Australian National Cabinet Meeting to Focus on Oil Supply -- Market Talk

2026. g. 29. marts 09:30 UTC

Iegādes, apvienošanās, pārņemšana

Food Mega-Mergers Hardly Ever Work. Could McCormick-Unilever Be Different? -- Heard on the Street -- WSJ

2026. g. 28. marts 08:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 27. marts 20:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 27. marts 19:16 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Futures Rise On Uncertainty Ahead of Weekend -- Market Talk

2026. g. 27. marts 19:07 UTC

Tirgus saruna

U.S. Natural Gas Gains As April Contract Expires -- Market Talk

2026. g. 27. marts 19:04 UTC

Tirgus saruna

Gold Rises But Can't Finish the Week Positive -- Market Talk

2026. g. 27. marts 19:03 UTC

Tirgus saruna

Galvenie ziņu notikumi

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 27. marts 19:02 UTC

Tirgus saruna

Galvenie ziņu notikumi

Among Central Banks, Canada Has Room to Handle Oil Inflation -- Market Talk

2026. g. 27. marts 18:12 UTC

Tirgus saruna

Foreign Fuels and Feedstocks to Get RINs Until 2028 -- Market Talk

2026. g. 27. marts 17:36 UTC

Galvenie ziņu notikumi

The Iran War and Oil Prices Bring Risk of Deeper Market Lows. There Are Echoes of 2008. -- Barrons.com

2026. g. 27. marts 17:34 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Delivery Hero Shares Bounce as Stake-Sale Report Whets Investor Appetites -- Market Talk

2026. g. 27. marts 17:29 UTC

Tirgus saruna

U.S. Oil Rig Count Falls By 5 to 409 -- Market Talk

2026. g. 27. marts 16:38 UTC

Tirgus saruna

Carnival's Outlook Assumes Oil Prices Will Come Down -- Market Talk

2026. g. 27. marts 16:32 UTC

Tirgus saruna

Galvenie ziņu notikumi

Chinese Exposure to Higher Energy Costs Seen as Limited -- Market Talk

2026. g. 27. marts 16:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 27. marts 15:43 UTC

Tirgus saruna

Galvenie ziņu notikumi

Hormuz Closure Sends Tanker Rates to Record Highs -- Market Talk

2026. g. 27. marts 15:25 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 27. marts 15:25 UTC

Tirgus saruna

Swiss Franc Dented by Rising European Yields, SNB Intervention Threats -- Market Talk

Salīdzinājums

Cenas izmaiņa

Evolent Health Inc Prognoze

Cenas mērķis

By TipRanks

150.68% augšup

Prognoze 12 mēnešiem

Vidējais 5.54 USD 150.68%

Augstākais 10 USD

Zemākais 3 USD

Pamatojoties uz 15 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Evolent Health Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

15 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 15 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Evolent Health Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

10.33 / 10.95Atbalsts un pretestība

Recent bullish events outweigh bearish events.

All events are bullish.

All events are bearish.

Noskaņojums

By Acuity

280 / 349 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.